会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • CONJUGATES OF ERYTHROPOIETIN (PEP) WITH POLYETHYLENE GLYCOL (PEG)
    • 聚乙二醇(PEG)与聚乙二醇(PEG)的结合
    • WO0249673A3
    • 2003-01-23
    • PCT/EP0114434
    • 2001-12-08
    • HOFFMANN LA ROCHE
    • BURG JOSEFENGEL ALFREDFRANZE REINHARDHILGER BERNDSCHURIG HARTMUT ERNSTTISCHER WILHELMWOZNY MANFRED
    • A61K47/48A61K38/18C07K14/505
    • A61K47/62A61K47/60
    • The present invention refers to conjugates of erythropoietin with poly(ethylene glycol) comprising an erythropoietin glycoprotein having an N-terminal alpha -amino group and having the in vivo biological activity of causing bone marrow cells to increase production of reticulocytes and red blood cells and selected from the group consisting of human erythropoietin and analogs thereof which have sequence of human erythropoietin modified by the addition of from 1 to 6 glycosylation sites or a rearrangement of at least one glycosylation site; said glycoprotein being covalently linked to one poly(ethylene glycol) group of the formula -CO-(CH2)x-(OCH2CH2)m-OR with the -CO of the poly(ethylene glycol) group forming an amide bond with said N-terminal alpha -amino group; wherein R is lower alkyl; x is 2 or 3; and m is from about 450 to about 1350.
    • 本发明涉及促红细胞生成素与聚(乙二醇)的缀合物,其包含具有N-末端α-氨基的促红细胞生成素糖蛋白,具有引起骨髓细胞增加网织红细胞和红细胞产生的体内生物学活性, 由人促红细胞生成素及其类似物组成,其具有通过加入1至6个糖基化位点或至少一个糖基化位点的重排而修饰的人促红细胞生成素序列; 所述糖蛋白与式-CO-(CH2)x-(OCH2CH2)m-OR的一个聚(乙二醇)基团共价连接,聚(乙二醇)基团的-CO与所述N- 末端α-氨基; 其中R是低级烷基; x为2或3; m为约450至约1350。
    • 7. 发明申请
    • ERYTHROPOIETIN CONJUGATES WITH POLYETHYLENGLYCOL
    • 聚乙烯吡咯烷酮与聚乙烯醇共聚
    • WO0102017A3
    • 2001-08-09
    • PCT/EP0006009
    • 2000-06-28
    • HOFFMANN LA ROCHE
    • BURG JOSEFHILGER BERNDJOSEL HANS-PETER
    • A61K38/00A61K38/22A61K47/48A61P7/06A61P13/12A61P31/18A61P35/00C07K14/505
    • C07K14/505A61K38/00A61K47/60
    • Erythropoietin glycoprotein conjugates are disclosed, said conjugates comprise an erythropoietin glycoprotein having at least one free amino group and having the in vivo biological activity of causing bone marrow cells to increase production of reticulocytes and red blood cells and selected from the group consisting of human erythropoietin and analogs thereof which have the primary structure of human erythropoietin modified by the addition of from 1 to 6 glycosylation sites or by the rearrangement of at least one glycosylation site; said glycoprotein being covalently linked to form one to three lower-alkoxy poly(ethylene glycol) groups, each poly(ethylene glycol) group being covalently linked to the glycoprotein via a linker of the formula -C(O)-X-S-Y- with the C(O) of the linker forming an amide bond with one of said amino groups, wherein X and Y are as defined in the description and claims, the average molecular weight of each poly(ethylene glycol) moiety is from about 20 kilodaltons to about 40 kilodaltons, and the molecular weight of the conjugate is from about 51 kilodaltons to about 175 kilodaltons.
    • 所述缀合物包含具有至少一个游离氨基并且具有引起骨髓细胞的体内生物学活性以增加网织红细胞和红细胞的产生的促红细胞生成素糖蛋白,并选自 由人类红细胞生成素及其类似物组成的组,其具有通过加入1至6个糖基化位点或通过重排至少一个糖基化位点而修饰的促红细胞生成素的一级结构; 所述糖蛋白共价连接以形成一至三个低级烷氧基聚(乙二醇)基团,每个聚(乙二醇)基团通过式-C(O)的连接体与糖蛋白共价连接 )-XSY-,其中所述连接体的C(O)与所述氨基之一形成酰胺键,其中X和Y如说明书和权利要求中所定义,每个聚(乙二醇)部分的平均分子量为 约20千道尔顿至约40千道尔顿,共轭物的分子量为约51千道尔顿至约175千道尔顿。